CJ. Rubidge, JN. Scragg; PB. O'Dowd; SJ. Powell, Clinical trials of hycanthone (etrenol) in urinary tract bilharziasis., in S Afr Med J, vol. 44, n. 43, Ott 1970, p. 1246, PMID5486116.
KC. Shekhar, Schistosomiasis drug therapy and treatment considerations., in Drugs, vol. 42, n. 3, Set 1991, pp. 379-405, PMID1720380.
IB. Weinstein, R. Chernoff; I. Finkelstein; E. Hirschberg, Miracil D: an inhibitor of ribonucleic acid synthesis in Bacillus subtilis., in Mol Pharmacol, vol. 1, n. 3, novembre 1965, pp. 297-305, PMID4954156.
RE. Bases, F. Mendez, Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy., in Int J Radiat Oncol Biol Phys, vol. 37, n. 5, marzo 1997, pp. 1133-7, PMID9169823.
M. Luo, MR. Kelley, Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone., in Anticancer Res, vol. 24, n. 4, pp. 2127-34, PMID15330152.
DM. Blair, F. Hawking, Miracil; clinical trial on patients infected with Schistosoma haematobium and S. mansoni., in Br J Pharmacol Chemother, vol. 4, n. 1, marzo 1949, pp. 68-80, PMID18124427.
AT. Colaco, [Miracil D in the treatment of vesical schistosomiasis]., in An Inst Med Trop (Lisb), vol. 6, Dic 1949, pp. 149-63, PMID14771468.
A. Halawani, A. Hafez, Miracil D; effect on B. mansoni in vitro and in the treatment of urinary bilharziasis., in J Egypt Med Assoc, vol. 32, n. 1, gennaio 1949, pp. 29-51, PMID18128628.
J. Newsome, A. Halawani, The treatment of urinary bilharzia in Egypt by miracil D., in Trans R Soc Trop Med Hyg, vol. 44, n. 1, Lug 1950, pp. 67-76, PMID15443041.